Cheng Sohanya Roshan 4
4 · Karyopharm Therapeutics Inc. · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-06-08$2.35/sh−1,839$4,322→ 211,501 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 7, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
- [F2]Includes 2,653 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 28, 2023.